MAPT and Alzheimer disease: Finally, hippocampal DYRK1A knockdown in PS19 mice selectively decreased insoluble p-TauSer396 and p-TauSer404 and suppressed tau-mediated neuroinflammatory responses/AD-related glial dynamics.